Possibly 1 out of 5 - the one being MSB - I'll check them all when you have 5. Amplia Therapeutics Annual Report YE 31/3/23 pg48 “going concern” and audit report pg65
Last year. This is 2024.
Pharmaxis AR YE 30/6/23 pg33 “going concern” and audit report pg62
Same.
Mesoblast AR YE 30/6/24 pg6 “Risks; accumulated deficit $908.8 million; require substantial additional financing” and pg169 “going concern - material uncertainty”
Possibly 1 out of 5.
Neuren Pharmaceuticals AR YE 31/12/20 pg36 “material uncertainties and going concern basis”
Four years ago. Actinogen Medical AR YE 30/6/23 pg43 “going concern” and audit report pg64
Last year.
I think you now owe me an apology and you need to consider retracting your comments in relation to my post!
Not yet.
CYP Price at posting:
20.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)